BIOREM Inc.
BRM.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 328.47% | 456.81% | 161.91% | 194.64% | -35.70% |
| Total Depreciation and Amortization | 271.98% | 33.74% | -10.05% | 213.88% | -58.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 274.65% | 364.39% | 287.83% | 902.69% | -15.52% |
| Change in Net Operating Assets | -106.85% | 18.68% | 129.80% | -259.75% | 161.70% |
| Cash from Operations | 18.67% | 40.08% | 320.59% | -98.59% | 247.38% |
| Capital Expenditure | 100.00% | 99.00% | -433.27% | 299.77% | -429.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 99.00% | -433.27% | 299.77% | -429.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 79.06% | -2.78% | -32.23% | 50.83% | -142.69% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.06% | -951.37% | -397.36% | 50.99% | -227.20% |
| Foreign Exchange rate Adjustments | 337.36% | -79.04% | 127.70% | 93.19% | -113.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 315.52% | 36.94% | 293.29% | -143.91% | 206.16% |
